GKNM Hospital > Clinical Research & Trial

Clinical Research & Trial

About Clinical Research & Trial

V N CANCER CENTER started its clinical research services in 2008. We provide clinical research services for pharmaceutical and biotechnology product development from Phase I to Phase IV.  G.Kuppuswamy Naidu Memorial Hospital has an efficient PI group Specialities in major therapeutic areas like Oncology, Cardiology and Endocrinology.

Investigator Initiated Trials

Medical Oncology

A Prospective, Multicenter, Observational Study Examining The clinical Utility Of Canscript In Routine Clinical Practice” – Dr.A.Rajkumar

  • person
    OfficeVNCC, C Block, 1st Floor
  • mail
    Timing08:00 am to 04:00 pm
  • call
    Contact0422 – 4305704


Agency Sponsored Trials

Medical Oncology

Aspirin for Dukes C and High Risk Dukes B colorectal cancers-An international, Multi centre, Double blind, Randomized Placebo Controlled Phase III Trial – INDOX, Dr.B.Sivanesan

Radation Oncology

  • Resource sparing curative treatment for Rectal Cancer – IAEA, Dr. M. Nagarajan
  • A randomized multicenter trial of accelerated hypo – vs. normo–fractionated radiotherapy for head and neck squamous cell carcinoma (IAEA-HYPNO trial) – IAEA, M. Nagarajan
  • Role of Human Papillomavirus Infection and other co-factors in the Aetiology of Head and Neck cancer India and Europe – WHO/IARC/ICMR, M. Nagarajan
Company Sponsored Trials

Medical Oncology

  • Prospective, multi-centre, randomized, open-label, two-arm, parallel group, active control, comparative clinical study to evaluate efficacy, safety and pharmacokinetics of XXXXX/ Avastin™ when given intravenously in patients with Metastatic colorectal cancer – Dr. B. Sivanesan
  • A Multi-center, randomized, double-blind, vehicle-controlled, phase-2 trial to evaluate the efficacy and safety of two concentrations of topical povidone-iodine nail solution (VBP-926) for the treatment of chemotherapy-associated paronychia in cancer patient– Dr. B. Sivanesan
  • A Phase II/III Pivotal, Open-label, Randomized, 3Arm Study to Assess the Efficacy of LNP3794 Monotherapy or in Combination with Docetaxel, Compared with Docetaxel Alone, in Patients with RAS Mutation Positive Locally Advanced and Metastatic Non-Small Cell Lung Cancer – Dr. B. Sivanesan
  • Prospective, multi-centre, randomized, open-label, two arm, parallel group, active-control, comparative clinical study to evaluate efficacy, safety and pharmacokinetics of XXXX/ Herceptin®(HerclonTM) when given intravenously in patients with Metastatic HER2-Over expressing Breast Cancer – Dr. A. Rajkumar

Radation Oncology

A Phase III, open-label,Randomized, Multi-center study of the effects of Leukocyte Interleukin, injection[xxxxxx} plus standard of care (Surgery + Radiotherapy or Surgery+Concurrent Chemoradiotherapy) in subjects with Advanced primary Squamous Cell Carcinoma of the oral cavity/Soft palate versus standard of care only – CEL SCI, Dr. M. Nagarajan

Heamato Oncology

  • Observational Follow up for patient who has received BCD-020 (rituximab, CJSC BIOCAD, Russia) / Mabthera for CD20-positive indolent non-Hodgkin lymphoma in BIORIX study –
    Dr. B. Sivanesan
  • A Phase 3 Randomized, Controlled, Open-Label Study of Selinexor, Bortezomib, and Dexamethasone (SVD) versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) – Dr. B. Sivanesan
  • SADAL: A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients with Relapsed/ Refractory Diffuse Large B-Cell Lymphoma (DLBCL) – Dr. B. Sivanesan


A legacy of trust, value, and reputation

Years of Service

Compassionate and more reliable medical services since the day of inauguration.


Founded with a vision to make medical services accessible and affordable for everyone.


Comprehensive multi speciality medical care with 31 core specialities and 12 allied medical services.

Sthescope Icon

Make an Appointment

Find Doctor
Find a Doctor

View Profiles